NVS NYSE
Novartis AG
1W: +4.4%
1M: +0.7%
3M: +7.3%
YTD: +12.7%
1Y: +32.9%
3Y: +66.9%
5Y: +104.4%
$159.85
+3.74 (+2.40%)
Weekly Expected Move ±3.8%
$143
$149
$155
$161
$167
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$303.8B
52W Range112.34-170.46
Volume1,626,942
Avg Volume1,825,862
Beta0.49
Dividend$4.74
Analyst Ratings
Company Info
CEOVas Narasimhan
Employees75,267
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date1996-11-07
Websitenovartis.com
Lichtstrasse 35
Basel, BS 4056
CH
Basel, BS 4056
CH
41 61 324 1111
About Novartis AG
Novartis AG is a holding company, which engages in the business of developing, manufacturing, and marketing healthcare products. Its product portfolio is heavily focused on innovative prescription medicines, especially oncology, immunology, neuroscience, and cardiovascular diseases, supplemented by established older brands and a wide range of specialized therapies. The company was founded on February 29, 1996 and is headquartered in Basel, Switzerland.
Latest News
Recent Insider Trades
No insider trades found